Core Insights - Climb Bio, Inc. will participate in the 24th Annual Needham Healthcare Conference, which will be held virtually from April 7-10, 2025 [1] - The conference will include presentations and one-on-one investor meetings, with Climb Bio's presentation scheduled for April 10, 2025, at 8:45 a.m. ET [2] Company Overview - Climb Bio, Inc. is a clinical-stage biotechnology company focused on developing therapeutics for immune-mediated diseases [2] - The company's pipeline includes budoprutug, an anti-CD19 monoclonal antibody that has shown B-cell depletion and potential applications for a variety of B-cell mediated diseases [2] - Another key product in development is CLYM116, an anti-APRIL monoclonal antibody currently undergoing IND-enabling studies for IgA nephropathy [2]
Climb Bio to Present at the 24th Annual Needham Virtual Healthcare Conference